Risk of epilepsy among patients with atopic dermatitis: A nationwide longitudinal study

Epilepsia

Volumn 55, Issue 8, 2014, Pages 1307-1312

  Chen, Mu Hong ^a,b   Wu, Yi Hui ^a   Su, Tung Ping ^a,b   Chen, Ying Sheue ^a,b   Hsu, Ju Wei ^a,b   Huang, Kai Lin ^a,b   Li, Cheng Ta ^a,b   Lin, Wei Chen ^a   Chang, Wen Han ^a   Chen, Tzeng Ji ^a,b   Bai, Ya Mei ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Atopic dermatitis; Comorbidities; Epilepsy

Indexed keywords

ADULT; AGED; ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; CEREBROVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; ENCEPHALITIS; EPILEPSY; FEMALE; FOLLOW UP; HEAD INJURY; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MENINGITIS; NERVOUS SYSTEM INFLAMMATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR;

ATOPIC DERMATITIS; COMORBIDITIES; EPILEPSY;

ADOLESCENT; ADULT; AGED; DATABASES, FACTUAL; DERMATITIS, ATOPIC; EPILEPSY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS; TAIWAN; YOUNG ADULT;

EID: 84905583366     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12667     Document Type: Article

References (40)

1. Browne TR, Holmes GL,. Epilepsy. N Engl J Med 2001; 344: 1145-1151.
2. Chang BS, Lowenstein DH,. Epilepsy. N Engl J Med 2003; 349: 1257-1266.
3. Kwan P, Schachter SC, Brodie MJ,. Drug-resistant epilepsy. N Engl J Med 2011; 365: 919-926.
4. Shinnar S, Pellock JM,. Update on the epidemiology and prognosis of pediatric epilepsy. J Child Neurol 2002; 17 (Suppl. 1): S4-S17.
5. de Boer HM, Mula M, Sander JW,. The global burden and stigma of epilepsy. Epilepsy Behav 2008; 12: 540-546.
6. Murray CJ, Richards MA, Newton JN, et al. UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013; 381: 997-1020.
7. Ngugi AK, Bottomley C, Kleinschmidt I, et al. Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 2010; 51: 883-890.
8. Mao LY, Ding J, Peng WF, et al. Interictal interleukin-17A levels are elevated and correlate with seizure severity of epilepsy patients. Epilepsia 2013; 54: e142-e145.
9. Tiwari P, Dwivedi R, Mansoori N, et al. Do gene polymorphism in IL-1beta, TNF-alpha and IL-6 influence therapeutic response in patients with drug refractory epilepsy? Epilepsy Res 2012; 101: 261-267.
10. Aronica E, Crino PB,. Inflammation in epilepsy: clinical observations. Epilepsia 2011; 52 (Suppl. 3): 26-32.
11. Vezzani A, Aronica E, Mazarati A, et al. Epilepsy and brain inflammation. Exp Neurol 2013; 244: 11-21.
12. Vezzani A, Granata T,. Brain inflammation in epilepsy: experimental and clinical evidence. Epilepsia 2005; 46: 1724-1743.
13. Skaper SD, Facci L, Giusti P,. Mast cells, glia and neuroinflammation: partners in crime? Immunology 2014; 141: 314-327.
14. Skaper SD, Giusti P, Facci L,. Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J 2012; 26: 3103-3117.
15. Leung DY, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest 2004; 113: 651-657.
16. Novak N, Simon D,. Atopic dermatitis-from new pathophysiologic insights to individualized therapy. Allergy 2011; 66: 830-839.
17. Chen CP, Lin SP, Chern SR, et al. A de novo 7.9 Mb deletion in 22q13.2->qter in a boy with autistic features, epilepsy, developmental delay, atopic dermatitis and abnormal immunological findings. Eur J Med Genet 2010; 53: 329-332.
18. Arck P, Paus R,. From the brain-skin connection: the neuroendocrine- immune misalliance of stress and itch. NeuroImmunoModulation 2006; 13: 347-356.
19. Misery L,. Atopic dermatitis and the nervous system. Clin Rev Allergy Immunol 2011; 41: 259-266.
20. Usui C, Hatta K, Arai H, et al. Brain-skin connection: is atopic dermatitis associated with demonstrable basal ganglia dysfunction? Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 164-165.
21. Chen MH, Su TP, Chen YS, et al. Asthma and attention-deficit/ hyperactivity disorder: a nationwide population-based prospective cohort study. J Child Psychol Psychiatry 2013; 54: 1208-1214.
22. Shen CC, Tsai SJ, Perng CL, et al. Risk of Parkinson disease after depression: a nationwide population-based study. Neurology 2013; 81: 1538-1544.
23. Aronica E, Fluiter K, Iyer A, et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 2010; 31: 1100-1107.
24. Omran A, Peng J, Zhang C, et al. Interleukin-1beta and microRNA-146a in an immature rat model and children with mesial temporal lobe epilepsy. Epilepsia 2012; 53: 1215-1224.
25. Vezzani A, Friedman A,. Brain inflammation as a biomarker in epilepsy. Biomark Med 2011; 5: 607-614.
26. Samland H, Huitron-Resendiz S, Masliah E, et al. Profound increase in sensitivity to glutamatergic- but not cholinergic agonist-induced seizures in transgenic mice with astrocyte production of IL-6. J Neurosci Res 2003; 73: 176-187.
27. Akassoglou K, Probert L, Kontogeorgos G, et al. Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 1997; 158: 438-445.
28. Peltola J, Palmio J, Korhonen L, et al. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res 2000; 41: 205-211.
29. Ravizza T, Boer K, Redeker S, et al. The IL-1beta system in epilepsy-associated malformations of cortical development. Neurobiol Dis 2006; 24: 128-143.
30. Silverman AJ, Sutherland AK, Wilhelm M, et al. Mast cells migrate from blood to brain. J Neurosci 2000; 20: 401-408.
31. Galli SJ, Tsai M, Piliponsky AM,. The development of allergic inflammation. Nature 2008; 454: 445-454.
32. Yarlagadda A, Alfson E, Clayton AH,. The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry (Edgmont) 2009; 6: 18-22.
33. Ishiuji Y, Coghill RC, Patel TS, et al. Distinct patterns of brain activity evoked by histamine-induced itch reveal an association with itch intensity and disease severity in atopic dermatitis. Br J Dermatol 2009; 161: 1072-1080.
34. Raison CL, Capuron L, Miller AH,. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006; 27: 24-31.
35. Rosenkranz MA, Busse WW, Johnstone T, et al. Neural circuitry underlying the interaction between emotion and asthma symptom exacerbation. Proc Natl Acad Sci USA 2005; 102: 13319-13324.
36. Gharagozlou M, Farhadi E, Khaledi M, et al. Association between the interleukin 6 genotype at position -174 and atopic dermatitis. J Investig Allergol Clin Immunol 2013; 23: 89-93.
37. Behniafard N, Gharagozlou M, Farhadi E, et al. TNF-alpha single nucleotide polymorphisms in atopic dermatitis. Eur Cytokine Netw 2012; 23: 163-165.
38. Esparza-Gordillo J, Schaarschmidt H, Liang L, et al. A functional IL-6 receptor (IL6R) variant is a risk factor for persistent atopic dermatitis. J Allergy Clin Immunol 2013; 132: 371-377.
39. Theoharides TC, Zhang B,. Neuro-inflammation, blood-brain barrier, seizures and autism. J Neuroinflammation 2011; 8: 168.
40. Silverberg JI, Joks R, Durkin HG,. Allergic disease is associated with epilepsy in childhood: a US population-based study. Allergy 2014; 69: 95-103.